Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background</h3><p>Diabetic nephropathy (DN) is a severe microvascular complication of diabetes with prominent morbidity and mortality. At present, there are hardly any effective drugs to treat DN. Epiberberine (EPI), an isoquinoline alkaloid, has attracted considerable attention due to its anti-hyperglycemic, anti-hyperlipidemic, and anti-inflammatory functions. However, whether there is a protective effect of EPI on DN has not been reported.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Purpose</h3><p>The research was aimed to investigate the activities of EPI alleviating kidney damage in <em>db/db</em> mice and to explore its possible mechanisms.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Study design</h3><p>The <em>db/db</em> mice and high-glucose (HG) induced glomerular mesangial cells (GMCs) were used to explore the protective effect of EPI on DN <em>in vivo</em> and <em>in vitro</em>.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>The changes in fasting blood glucose, metabolic index, renal function, and histopathological morphology in <em>db/db</em> mice were detected to evaluate the therapeutic effect of EPI. Then, renal transcriptome and molecular docking were used to screen the key targets. Subsequently, HG-induced GMCs through mimicing the pathological changes in DN were utilized to study the renal protective effects of EPI and its potential mechanism.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>The results <em>in vivo</em> showed that EPI administration for 8 weeks significantly alleviated diabetes-related metabolic disorders, improved renal functions, and relieved the histopathological abnormalities of renal tissue, especially renal fibrosis in <em>db/db</em> mice. The results <em>in vitro</em> showed that EPI inhibited the proliferation and induced the G2/M phase arrest of HG-induced GMCs. Moreover, a key gene <em>Angiotensinogen</em> (<em>Agt</em>) was screen out by the RNA-seq of kidney and molecular docking, and EPI reduced Agt, TGFβ1, and Smad2 expression <em>in vitro</em> and <em>in vivo</em>. Noteworthy, <em>Agt</em> knockdown by siRNA significantly attenuated these beneficial efficacies exerted by EPI, indicating that Agt played a crucial role in the process of EPI improving DN.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>These findings suggested that EPI might be a potential drug for the treatment of DN dependent on the Agt-TGFβ/Smad2 pathway.</p>

The Proteasome Inhibitor , MG 132 , Attenuates Diabetic Nephropathy by Inhibiting SnoN Degradation in Vivo and in Vitro

TGF-β signaling in diabetic nephropathy: An update

Protective Role of Low-Dose TGF-β1 in Early Diabetic Nephropathy Induced by Streptozotocin.

G-CSF Prevents Progression of Diabetic Nephropathy in Rat

Tangshenning Attenuates High Glucose-Induced Podocyte Injury via Restoring Autophagy Activity through Inhibiting mTORC1 Activation

Protective effect of a poly-phytocompound on early stage nephropathy secondary to experimentally-induced diabetes

The Role of Mood on Emotional Agents Behaviour

Nephrin loss is reduced by grape seed proanthocyanidins in the experimental diabetic nephropathy rat model

Rescue of Mesangial Cells from High Glucose-Induced Over-Proliferation and Extracellular Matrix Secretion by Hydrogen Sulfide.

Neutralization of TGF-β by Anti-TGF-β Antibody Attenuates Kidney Hypertrophy and the Enhanced Extracellular Matrix Gene Expression in STZ-Induced Diabetic Mice

Gene expression profiling in glomeruli of diabetic nephropathy rat

MG132, Attenuates the Retinal Vascular Injury Through the Upregulation of Nrf2 Expression.

Low TGFβ1 expression prevents and high expression exacerbates diabetic nephropathy in mice

Smad2 Phosphorylation in Diabetic Kidney Tubule Epithelial Cells is Associated with Modulation of Several Transforming Growth Factor-β Family Members.

Ginsenoside Rg1 Alleviates Podocyte EMT Passage by Regulating AKT/GSK3 Β/β-Catenin Pathway by Restoring Autophagic Activity

Disparate Phospho-Smad2 Levels in Advanced Type 2 Diabetes Patients with Diabetic Nephropathy and Early Experimental Db/db Mouse Model.

Folding Optimization In Vivo Uncovers New Chaperones.

Geniposide Improves Diabetic Nephropathy by Enhancing ULK1-Mediated Autophagy and Reducing Oxidative Stress through AMPK Activation

[Frequency of decisions to forgo (artificial) administration of food and fluids at life's end].

Epiberberine ameliorated diabetic nephropathy by inactivating the angiotensinogen (Agt) to repress TGFβ/Smad2 pathway

Population structure and dynamics of an evergreen shade herb, Ainsliaea apiculata (Asteraceae), with special reference to herbivore effects